Science Headlines
-
UPDATE 1-Trump Jr. tweet likening Syrian refugees to poisoned Skittles irks candy maker
NEW YORK, Sept 20 (Reuters) - The maker of Skittles candies on Tuesday objected to a social media post by Donald Trump Jr. in which the Republican presidential hopeful's son compared admitting Syrian refugees to the United States to eating poisoned pieces of the brightly colored, fruit-flavored treats.
-
Allergan buys second fatty liver-disease company
(Reuters) - Allergan Inc on Tuesday said it had paid $50 million for Akarna Therapeutics Ltd, a privately held company developing treatments for a incurable fatty liver disease called NASH.
-
Are U.S. public schools prepared for an emergency?
(Reuters Health) - More than a fifth U.S. school districts lack comprehensive plans to respond to natural disasters, epidemic diseases or other emergencies, a new report finds.
-
Medicare EpiPen spending outpaces prescription growth -Kaiser report
NEW YORK, Sept 20 (Reuters) - U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis.
-
Giving babies eggs and nuts early may avert allergies
(Reuters Health) - Infants who get a taste of eggs and peanuts starting when they’re as young as 4 months old may have a lower risk of developing allergies to those foods than babies who try them later, a research review suggests.
-
Mylan shares languish at low valuation as EpiPen hearing nears
NEW YORK (Reuters) - Shares of Mylan NV are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment.
-
China Vitamin C price-fixing verdict voided by U.S. appeals court
NEW YORK (Reuters) - A U.S. appeals court on Tuesday threw out a $147.8 million price-fixing verdict against two Chinese companies that were accused of conspiring to raise prices and lower supply of vitamin C sold to U.S. purchasers.
-
UPDATE 1-Northern Gateway pipeline project will not appeal Canadian court decision
TORONTO, Sept 20 (Reuters) - Oil company Enbridge Inc's Northern Gateway pipeline project will not appeal a recent Canadian Federal Court of Appeal decision that reversed its approval pending consultations with aboriginal groups, it said on Tuesday.
-
VW's Audi head questioned over emissions scandal
HANOVER, Germany (Reuters) - The head of Volkswagen's
luxury car division Audi has been questioned by investigators looking into the company's emissions scandal, VW Chief Executive Matthias Mueller said on Tuesday. -
McAfee's MGT sinks 21 percent after NYSE refuses share listing
SAN FRANCISCO (Reuters) - Shares of MGT Capital Investments
, led by anti-virus software pioneer John McAfee, dropped 21 percent on Tuesday after it said the New York Stock Exchange denied approval of the listing of shares for a planned merger with anti-spyware company D-Vasive Inc. - More Science Headlines»


